Twenty-seven healthy male volunteers participated in a double-blind, five-way crossover designed comparison of the new, selective H,-receptor antagonist cetirizine (10 mg q.d.) and terfenadine (60 mg b i d . and 120 mg q.d.) versus the older H,-receptor antagonist triprolidine ( 5 mg b.i.d.) and placebo.Medication was administered during four consecutive days. Subjects were tested on the 1st and 4th treatment day. On each test day subjects drove an instrumented vehicle over a 100 km highway circuit while attempting to maintain a constant speed (90 k d h r ) and a steady lateral position within the right traffic lane. Thereafter they performed three computerized memory tasks. On the 4th treatment day, sleep latency was measured before and after the driving test. On both days, triprolidine significantly impaired performance in the driving and psychometric tests. Triprolidine also significantly reduced sleep latency in comparison to placebo on the 4th treatment day. Terfenadine 60 mg b.i.d. impaired psychometric performance after subchronic treatment.It was concluded that cetirizine, like terfenadine, belongs to the newer class of antihistamines and can be safely used by patients who continue their daily activities.
The main purpose of this study was to compare the sensitivity of a driving simulator test model (TS2) with a standard on-the-road driving test, after one night treatment with lormetazepam 1 mg, oxazepam 50 mg (as a verum) and placebo. The secondary purpose was to measure the effects of the intended drugs and placebo in the same subject sample, after two treatment nights in the morning and in the afternoon, on on-the-road driving performance. Eighteen healthy male volunteers received the three treatments (2 consecutive nights each) according to a double-blind, three-way crossover design. Time of administration was set at 22.00 hours each night. An on-the-road driving test and a simulator driving test were conducted in the morning following the first night. After the second treatment night, on-the-road driving tests were performed in the morning and in the afternoon. The on-the-road driving test consisted of operating an instrumental automobile over a 100 km highway circuit at a constant speed (90 kmh) and constant steady lateral position between the right lane boundaries. Primary performance measure was the SD of lateral position (SDLP). The simulator test consisted of repeatedly performing 'curve-following' manoeuvres, which was the main tracking control task, while simultaneously reacting to secondary visual signs. Test parameters were the number of correctly executed manoeuvres (TC) and reaction time (RT). Oxazepam 50 mg seriously impaired, and lormetazepam 1 mg slightly impaired, on-the-road driving performance in the morning, both after the first and second treatment night. The drugs produced no significant effects in the afternoon test following the second night. In contrast with these results, neither oxazepam 50 mg nor lormetazepam 1 mg affected simulator tracking control after one night. No deterioration was found for reaction time. Correlational and multiple regression analyses were applied to determine relationships between SDLP, TC and RT. The major conclusion of this study was that the TS2 driving simulator test does not predict residual drug effects in the on-the-road driving test, and seems to be a less sensitive measure of sedative drug-induced impairment in contrast to the on-the-road driving test.KEY wows-Hypnotics, simulated driving, on-the-road driving. INTRODlJCTIONStudies of hypnotics have generally focused on their effects on sleep; however, it is also clear that they have effects which can extend beyond the usual sleep period. Among the risks associated with the use of hypnotics, the most prominent effect is decreased performance during the day following nocturnal administration (Hindmarch, 1980;Volkerts and O'Hanlon, 1986). This hangover or residual effect is not a side-effect, but merely an extension of the drug's primary action. It occurs because hypnotics produce sleepiness, reduce alertness, and thereby reduce performance efficiency. This poses * Author to whom correspondence should be addressed. a crucial problem for hypnotic users who must operate a motor vehicle or other dangerous m...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.